Host-directed therapeutic targets in macrophages and their ligands against mycobacteria tuberculosis

ABSTRACT Although current combination regimens of antibiotics have significantly improved tuberculosis (TB) cure rates, substantial challenges persist in the global effort to end TB. These include poor patient compliance, the emergence of drug-resistant strains due to prolonged treatments, and the p...

Full description

Bibliographic Details
Published in:	Infection and Immunity
Main Authors:	Jin Li, Yanmei Wang, Lei He, Luchuan Yang, Tao Tao, Lang Bai, Youfu Luo
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-10-01
Subjects:	host-directed therapies drug resistance macrophage polarization metabolism reprogramming Mycobacterium tuberculosis
Online Access:	https://journals.asm.org/doi/10.1128/iai.00063-25

Similar Items

Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria
by: Jia Wang, et al.
Published: (2025-05-01)

Glucose Metabolic Reprogramming of Macrophages Against Mycobacterium tuberculosis Infection
by: Liu T, et al.
Published: (2025-10-01)

Copper homeostasis; A rapier between mycobacteria and macrophages
by: Di Hu, et al.
Published: (2025-01-01)

The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis
by: Lu Huang, et al.
Published: (2018-08-01)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
by: Ivana Palucci, et al.
Published: (2020-01-01)

Host-directed therapy for tuberculosis
by: Na Tian, et al.
Published: (2025-04-01)

Single cell preparations of Mycobacterium tuberculosis damage the mycobacterial envelope and disrupt macrophage interactions
by: Ekansh Mittal, et al.
Published: (2023-02-01)

Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
by: Yilin Liu, et al.
Published: (2024-10-01)

Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
by: Jiaxing Yang, et al.
Published: (2023-10-01)

Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy
by: Gül Kilinç, et al.
Published: (2024-08-01)

Host-Directed Therapies for Tuberculosis
by: Eui-Kwon Jeong, et al.
Published: (2022-11-01)

Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection
by: Mohd Arish, et al.
Published: (2022-01-01)

Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy
by: Jiang Pi, et al.
Published: (2024-10-01)

Autophagy Induction as a Host-Directed Therapeutic Strategy against <em>Mycobacterium tuberculosis</em> Infection
by: Harresh Adikesavalu, et al.
Published: (2021-05-01)

Lessons from cross-pathogen studies: understanding the metabolic rewiring of macrophages upon infection
by: Marisol Perez-Toledo, et al.
Published: (2025-06-01)

Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions
by: Aarash Bordbar, et al.
Published: (2010-10-01)

GRN Activates TNFR2 to Promote Macrophage M2 Polarization Aggravating Mycobacterium Tuberculosis Infection
by: Bingling Zhang, et al.
Published: (2024-09-01)

Macrophage Heterogeneity in the Immunopathogenesis of Tuberculosis
by: Mohlopheni J. Marakalala, et al.
Published: (2018-05-01)

Marine-Fungi-Derived Gliotoxin Promotes Autophagy to Suppress <i>Mycobacteria tuberculosis</i> Infection in Macrophage
by: Jun Fu, et al.
Published: (2023-11-01)

Insights into the protein ubiquitinome in the host‒pathogen interplay during Mycobacterium tuberculosis infection
by: Qishun Feng, et al.
Published: (2025-08-01)

Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
by: Juan M. Cubillos-Angulo, et al.
Published: (2022-09-01)

Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis
by: Qingwen Zhang, et al.
Published: (2017-11-01)

The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
by: Retsepile E. Maphasa, et al.
Published: (2021-02-01)

Relevance of the Warburg Effect in Tuberculosis for Host-Directed Therapy
by: Bridgette M. Cumming, et al.
Published: (2020-09-01)

Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles
by: Shuhao Fan, et al.
Published: (2024-10-01)

Depletion of Mycobacterium tuberculosis transmembrane protein Rv3737 reduces pathogen survival and induces M1 macrophage polarization against tuberculosis
by: Zhangli Peng, et al.
Published: (2025-09-01)

Editorial: The role of macrophages in metabolic disorders
by: Yagna P. R. Jarajapu, et al.
Published: (2023-10-01)

Mycobacterium tuberculosis-macrophage interaction: Molecular updates
by: Haotian Bo, et al.
Published: (2023-03-01)

Zinc-limited Mycobacterium tuberculosis stimulate distinct responses in macrophages compared with standard zinc-replete bacteria
by: Endrei Marcantonio, et al.
Published: (2025-03-01)

Identification and Validation of Genes Related to Macrophage Polarization and Cell Death Modes Under Mycobacterium tuberculosis Infection
by: Yang Z, et al.
Published: (2024-02-01)

Host-Directed Therapies and Anti-Virulence Compounds to Address Anti-Microbial Resistant Tuberculosis Infection
by: Raphael Gries, et al.
Published: (2020-04-01)

Metabolic flux reprogramming in Mycobacterium tuberculosis-infected human macrophages
by: Khushboo Borah Slater, et al.
Published: (2023-11-01)

Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
by: Dahee Shim, et al.
Published: (2020-05-01)

Identification of Small Molecule Inhibitors against Mycobacteria in Activated Macrophages
by: Rebecca Vande Voorde, et al.
Published: (2022-09-01)

Baicalein inhibits mycobacterium tuberculosis-induced macrophage M1 polarization depending on the regulation of YY1/RAB10/TLR4 pathway
by: Qing Zhou, et al.
Published: (2025-10-01)

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
by: Li Zhao, et al.
Published: (2024-01-01)

Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Mycobacterium tuberculosis Infection
by: Jagadeeswara Rao Muvva, et al.
Published: (2020-01-01)

Dissecting the <i>Mycobacterium bovis</i> BCG Response to Macrophage Infection to Help Prioritize Targets for Anti-Tuberculosis Drug and Vaccine Discovery
by: Jamie Medley, et al.
Published: (2022-01-01)

Autophagy: A new strategy for host-directed therapy of tuberculosis
by: Seungwha Paik, et al.
Published: (2019-01-01)

Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosis
by: Nelson V Simwela, et al.
Published: (2025-03-01)